Comparison

CRUSE Control Urticaria vs Inside the Lab

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

CRUSE Control Urticaria

Manage chronic urticaria with daily symptom tracking and quality of life impact recording. Monitor treatment response and collaborate with your physician for improved care. This app is designed for individuals living with this common, debilitating skin condition.

Highlights
  • Daily symptom recording
  • Quality of life impact tracking
  • Treatment response monitoring
  • Physician collaboration tool
  • Disease activity documentation
Features
Read full description

CRUSE® is an APP developed by renowned dermatologists and allergoligists to help patients with Chronic Urticaria manage their condition. Take control of your Chronic Urticaria by recording your symptoms and impact on your quality of life in just a few minutes each day. Track how you respond to treatment and how it can be improved by using CRUSE in cooperation with your treating physician. Over 50 million people worldwide have Chronic Urticaria. It is a common condition that causes itchy wheals and/or swellings (angioedema) and can be very debilitating. To ensure optimal treatment, continuous monitoring and documentation of disease activity is essential. From now on, CRUSE® will take care of this for you. Your UCARE Team - With more than 130 member centres in 41 countries, GA²LEN’s Urticaria Centres of Reference and Excellence (UCARE network) is the biggest and most active consortium of urticariologists and urticaria centres. Are you a physician? Find out more on www.cruse-control-com

About

Inside the Lab

Read full description

Welcome to "Inside the Lab," the official immersive lab tour experience by Stallergenes Greer. Designed specifically for Healthcare Professionals (HCPs), this app transforms the complex world of allergen manufacturing into a captivating, interactive "phygital" (physical + digital) adventure.

Screenshots

CRUSE Control Urticaria3 screens
Inside the Lab4 screens

Verdict

The call

The clearest difference is update cadence: CRUSE Control Urticaria at fortnightly against Inside the Lab's every 2 months. On price, ads, in-app purchases and device support there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

UpkeepUpdate frequency

CRUSE Control Urticaria ships an update fortnightly, Inside the Lab every 2 months. The most recent releases landed on October 24, 2026 and October 15, 2026 respectively.

Scorecard1 real difference · 9 level
CRUSE Control Urticaria versus Inside the Lab: the parameters behind the verdict, then further details
ParameterCRUSE Control UrticariaInside the Lab
PriceFreeFree
Rating4.8 (8 ratings) — better—
Positive reviews75.9% of reviews—
Number of ratings8 — better—
Update frequencyFortnightly — betterEvery 2 months
AdsNoNo
In-app purchasesNoNo
MonetizationFree—
DevicesiPhone, iPodiPhone, iPad, iPod — better
Requires iOS15.515.0 — better
Further details — not scored
Size35 MB865 MB
Age rating17+4+
DeveloperMoxie GmbHStallergenes

In-app purchases

None

CRUSE Control Urticaria

No in-app purchases

None

Inside the Lab

No in-app purchases

Questions

Is CRUSE Control Urticaria free?
CRUSE Control Urticaria is free to download, with no in-app purchases.
Is Inside the Lab free?
Inside the Lab is free to download, with no in-app purchases.
Do CRUSE Control Urticaria or Inside the Lab have ads?
Neither CRUSE Control Urticaria nor Inside the Lab shows ads.
Which is updated more often, CRUSE Control Urticaria or Inside the Lab?
CRUSE Control Urticaria ships an update fortnightly, and Inside the Lab every 2 months. Most recently, CRUSE Control Urticaria was updated on October 24, 2026 and Inside the Lab on October 15, 2026.

Other comparisons